Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent (Biocellulose Mask, Farhorm®) in Patients Receiving Laser Treatment

Efficacy and Safety of Biocellulose Sheet From Coconut Juice Containing Anti-hyperpigmentation Agent (Biocellulose Mask, Farhorm®) in Patients Receiving Laser Treatment

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01806831

Enrollment

Registered

2013-03-07

Start date

2012-09-30

Completion date

2014-06-30

Last updated

2015-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Irritation, Skin Pigmentation

Brief summary

The laser areas treated with biocellulose sheet from coconut juice containing anti-hyperpigmentation agent (biocellulose mask, Farhorm®) heal faster than vaseline ointment which is a standard treatment.

Detailed description

Volar surface at upper arm (2X2 cm) on both sides were treated with semi ablative, 1,550 nm Erbium: glass fractional laser. Biocellulose sheet from coconut juice containing anti-hyperpigmentation agent (biocellulose mask,Farhorm®)was applied for 20 min on one side and the other side was treated with vaseline ointment. The redness, skin hydration and skin pigmentation were evaluated at that area before laser, immediately after laser and after applying the treatment. These parameters were compared between treatment (area treated with Biocellulose sheet from coconut juice containing anti-hyperpigmentation agent, biocellulose mask, Farhorm®) and control (vaseline ointment).

Interventions

DEVICEBiocellulose Mask, Farhorm®

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Age 20-50 years old * No skin problem such as inflammation, fresh wounds * Not receive laser treatment during last 3 months * No history of smoking or alcohol drinking * No allergy to licorice extract, Vit C, Vit E, arbutin or stearyl glycyrrhetinate * Willing to participate in this study and can comply with study protocol

Exclusion criteria

* Has history of hyperallergic reaction * Has wound(s) on face during last 4 weeks * Has history of eczema, psoriasis during last 6 months * Has laser treatment during last month * Use steroid, antibiotic, anti-inflammatory drugs or antihistamine during 3 days before recruiting * Had major surgery during last 12 months * Has history of cancer during last 12 months * Pregnant or lactation

Design outcomes

Primary

Measure	Time frame
The skin pigmentation immediately after laser therapy and after using biocellulose mask	Change from immediately after laser treatment and 30 min after laser and treatment with mask

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026